These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21442519)

  • 1. Ambiguous assignment of release data in stability studies.
    Fairweather WR
    J Biopharm Stat; 2011 May; 21(3):453-71. PubMed ID: 21442519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letters to the editor.
    Buck R; Altan S
    J Biopharm Stat; 2012; 22(1):206-10. PubMed ID: 22204535
    [No Abstract]   [Full Text] [Related]  

  • 3. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the probability of passing the USP dissolution test.
    Wang H
    J Biopharm Stat; 2007; 17(3):407-13. PubMed ID: 17479390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between HPLC precision and number of significant figures when reporting impurities and when setting specifications.
    Agut C; Segalini A; Bauer M; Boccardi G
    J Pharm Biomed Anal; 2006 May; 41(2):442-8. PubMed ID: 16472956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMDECOM: predicting the lifetime of screening compounds in DMSO solution.
    Zitha-Bovens E; Maas P; Wife D; Tijhuis J; Hu QN; Kleinöder T; Gasteiger J
    J Biomol Screen; 2009 Jun; 14(5):557-65. PubMed ID: 19483143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simulation study with statistical evaluation for the determination of non-isothermal kinetics conditions in drugs stability.
    Fernández de Aránguiz MY; de la Torre S; Berraondo MR
    Eur J Pharm Sci; 2007 Aug; 31(5):277-87. PubMed ID: 17540544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a semi-automated chemical stability system to analyze solution based formulations in support of discovery candidate selection.
    Hitchingham L; Thomas VH
    J Pharm Biomed Anal; 2007 Jan; 43(2):522-6. PubMed ID: 16996236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the shelf-life of drugs with mixed effects models.
    Chen JJ; Hwang JS; Tsong Y
    J Biopharm Stat; 1995 Mar; 5(1):131-40. PubMed ID: 7613558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling drug dissolution from controlled release products using genetic programming.
    Do DQ; Rowe RC; York P
    Int J Pharm; 2008 Mar; 351(1-2):194-200. PubMed ID: 18053658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the research of amorphous pharmaceuticals].
    Ying J; Lü Y; Du GH
    Yao Xue Xue Bao; 2009 May; 44(5):443-8. PubMed ID: 19618716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suggestions and recommendations for standardization of the systemic "routine" control during the production of the pharmaceutical dosage forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Mar; 110(3):131-46 contd. PubMed ID: 5561774
    [No Abstract]   [Full Text] [Related]  

  • 13. Have more confidence in your stability data: two points to consider.
    De Vore K
    J Pharm Biomed Anal; 2006 Apr; 41(1):293-8. PubMed ID: 16332424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Model of system of drug supply].
    Modemann W; Horn C; Weydling E
    Pharm Prax; 1969; 9():198-207. PubMed ID: 5369884
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.
    Morpurgo M; Teoli D; Pignatto M; Attrezzi M; Spadaro F; Realdon N
    Acta Biomater; 2010 Jun; 6(6):2246-53. PubMed ID: 20035908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 17. Monte Carlo simulations for the study of drug release from cylindrical matrix systems with an inert nucleus.
    Martínez L; Villalobos R; Sánchez M; Cruz J; Ganem A; Melgoza LM
    Int J Pharm; 2009 Mar; 369(1-2):38-46. PubMed ID: 19027839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greener pharmaceuticals.
    Clark JH; Breeden SW; Summerton L
    Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.